Lower limb amputations among individuals living with diabetes mellitus in low- and middle-income countries: A systematic review protocol

Eyitayo Omolara Owolabi, Davies Adeloye, Anthony Idowu Ajayi, Michael McCaul, Justine Davies, Kathryn M Chu
PLoS ONE 17(4): e0266907. https://doi.org/10.1371/journal.pone.0266907 23-04-2022 Systematic Reviews
Lower limb amputation (LLA) is one of the most life-altering complications of diabetes. We aimed to conduct a systematic review to determine the incidence and prevalence of DM-associated LLA in LMICs to better inform appropriate interventions and health system response.

Abstract

Background

The burden of diabetes mellitus (DM) and its associated complications continue to burgeon, particularly in low- and middle-income countries (LMICs). Lower limb amputation (LLA) is one of the most life-altering complications of DM, associated with significant morbidity, mortality and socio-economic impacts. High-income countries have reported a decreasing incidence of DM-associated LLA, but the situation in many LMICs is unknown. We aim to conduct a systematic review to determine the incidence and prevalence of DM-associated LLA in LMICs to better inform appropriate interventions and health system response.

Methods and analysis

A systematic search of the literature will be conducted on five databases: MEDLINE, Embase, Cumulative Index of Nursing and Allied Health Literature (CINAHL), Scopus and African Journal Online (AJOL). Only observational, quantitative studies reporting the incidence and/or prevalence of DM-related LLA will be considered. A validated study design-specific critical appraisal tool will be used to assess the risk of bias in individual studies. We will determine the incidence of LLA by examining the number of new cases of LLA among individuals with confirmed DM diagnosis during the specified period, while the prevalence will be based on the total number of all new and existing LLAs in a population. LLA will be considered as the resection of the lower limb from just above the knee to any point down to the toe. If heterogeneity is low to moderate, a random-effects meta-analysis will be conducted on extracted crude prevalence/incidence rates, with the median and interquartile range also reported. The systematic review will be performed in accordance with the JBI guideline for prevalence and incidence review. Study reporting will follow the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) guideline.

Contact

Click here to send us a message.

t: +27 (0)21 938 9962
e: This email address is being protected from spambots. You need JavaScript enabled to view it.
a: Teaching Building, Francie van Zijl Drive

Twitter: @MikeMcCaul3 | @cebhc | @SUBiostatsUnit

Connect on social media

About

Senior Lecturer in Epidemiology and Biostatistics, Division of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, South Africa. I have expertise in:

Clinical Epidemiology | Biostatistics | Evidence Synthesis | Guideline Development | Research Methods | Postgraduate Teaching and Learning | Prehospital Care | Student Supervision